Immunocapture based ChemiLuminescence ImmunoAssay (CLIA) for the determination of IgM antibodies to Rubella virus in human plasma and sera from patients undergoing an acute infection and from women in pregnancy monitoring.

The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.